Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

McNaughton A. et al, (2021)

Safety and Immunogenicity of the ChAdox1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 in HIV Infection

Frater J. et al, (2021)

Sequence analysis of SARS-CoV-2 in nasopharyngeal samples from patients with COVID-19 illustrates population variation and diverse phenotypes, placing the in vitro growth properties of B.1.1.7 and B.1.351 lineage viruses in context

Prince T. et al, (2021)

An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status

Lumley S. et al, (2021)

Antibody evasion by the P.1 strain of SARS-CoV-2

Dejnirattisai W. et al, (2021), Cell

Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections.

Eyre DW. et al, (2021), BMC infectious diseases, 21

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Lumley SF. et al, (2021), New England Journal of Medicine, 384, 533 - 540

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Zhou D. et al, (2021), Cell

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa P. et al, (2021), Cell

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Dejnirattisai W. et al, (2021), Cell

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

Pouwels KB. et al, (2021), The Lancet Public Health, 6, e30 - e38

Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine

Watanabe Y. et al, (2021), ACS Central Science

Convalescent plasma therapy for the treatment of patients with COVID ‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

Harvala H. et al, (2020), Transfusion Medicine

Antibodies to SARS-CoV-2 are associated with protection against reinfection

Lumley SF. et al, (2020)

The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers

Lumley SF. et al, (2020)

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng Y. et al, (2020), Nature Immunology, 21, 1336 - 1345

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Thompson CP. et al, (2020), Eurosurveillance, 25

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020

Lumley SF. et al, (2020), Eurosurveillance, 25

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Townsend A. et al, (2020)

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.

Wessel AW. et al, (2020), Nat Commun, 11

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?